Abstract
Sestrin 2 as a new biomarker in obesity and diabetes mellitus: A new key player in the metabolic regulation
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Health and Allied Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.